PSA screening and prostate cancer risk reduction.

  title={PSA screening and prostate cancer risk reduction.},
  author={Gerald L. Andriole},
  journal={Urologic oncology},
  volume={30 6},
Calendar year 2011 was eventful for Urologic Oncology, as it brought two significant challenges to the role of PSAbased screening for prostate cancer and to the concept of risk reduction with 5reductase inhibitors. In October, the U.S. Preventive Services Task Force issued a draft statement recommending against PSA-based screening for prostate cancer. The Task Force asked 4 key questions: Does PSA-based screening decrease prostate cancer-specific or all-cause mortality? What are the harms of… CONTINUE READING